Antipodes Partners’s Tapestry TPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,258,534
Closed -$51.1M 40
2021
Q4
$51.1M Sell
1,258,534
-827,661
-40% -$34M 1.84% 22
2021
Q3
$77.2M Buy
2,086,195
+745,895
+56% +$30.7M 2.64% 18
2021
Q2
$58.3M Sell
1,340,300
-224,384
-14% -$10M 2.1% 21
2021
Q1
$64.5M Sell
1,564,684
-65,403
-4% -$2.52M 2.61% 21
2020
Q4
$50.7M Sell
1,630,087
-1,751,175
-52% -$44.3M 2.2% 20
2020
Q3
$52.8M Sell
3,381,262
-110,884
-3% -$1.63M 2.42% 18
2020
Q2
$46.4M Buy
3,492,146
+826,377
+31% +$11.7M 2.1% 24
2020
Q1
$34.5M Buy
2,665,769
+198,991
+8% +$4.66M 1.81% 23
2019
Q4
$66.5M Sell
2,466,778
-1,062,985
-30% -$27.7M 3% 14
2019
Q3
$92M Sell
3,529,763
-867,360
-20% -$22.9M 4.39% 12
2019
Q2
$140M Buy
4,397,123
+318,716
+8% +$9.94M 6.4% 5
2019
Q1
$133M Sell
4,078,407
-184,270
-4% -$6.46M 6.55% 5
2018
Q4
$144M Buy
4,262,677
+1,302,103
+44% +$52.4M 7.11% 5
2018
Q3
$149M Buy
2,960,574
+319,748
+12% +$15.6M 6.91% 7
2018
Q2
$123M Buy
2,640,826
+58,420
+2% +$2.81M 5.86% 7
2018
Q1
$136M Buy
2,582,406
+826,998
+47% +$40.8M 6.09% 7
2017
Q4
$77.6M Buy
+1,755,408
New +$72.4M 4.55% 10

Other funds holding TPR

Antipodes Partners's TPR Position: Q1 2022 in Review

Antipodes Partners sold out of Tapestry (TPR) in Q1 2022, closing a stake of 1,258,534 shares — an estimated $51.1M sold.

Antipodes Partners first reported a position in TPR in Q4 2017 and held it in 17 quarters. The position peaked at $149M in Q3 2018. 547 funds tracked by Wall St. Rank hold TPR as of Q1 2022.

  • Antipodes Partners reported no remaining Tapestry position as of Q1 2022 after selling out during the quarter.
  • Antipodes Partners sold 1,258,534 Tapestry shares in Q1 2022, an estimated $51.1M.
  • Antipodes Partners first reported a position in Tapestry in Q4 2017 and held it in 17 quarters.
  • Antipodes Partners's Tapestry position peaked at $149M in Q3 2018.
  • 547 funds tracked by Wall St. Rank held Tapestry as of Q1 2022.

Based on Antipodes Partners's 13F filing for Q1 2022, filed 21 Apr 2022.